The aim of this study was to see how nifedipine counters the effects of cocaine on hepatic and brain enzymatic activity in rats and whether it affects urinary excretion of cocaine. Male Wistar rats were divided in four groups of six: control, nifedipine group (5 mg kg -1 i.p. a day for fi ve days); cocaine group (15 mg kg -1 i.p. a day for fi ve days), and the nifedipine+cocaine group. Twenty-four hours after the last administration, we measured neuronal nitric oxide synthase (nNOS) activity in the brain and cytochrome P450 quantity, ethylmorphine-N-demethylase, and anilinehydroxylase activity in the liver. Urine samples were collected 24 h after the last cocaine and cocaine+nifedipine administration. Urinary cocaine concentration was determined using the GC/MS method. Cocaine administration increased brain nNOS activity by 55 % (p<0.05) in respect to control, which indicates the development of tolerance and dependence. In the combination group, nifedipine decreased the nNOS activity in respect to the cocaine-only group. In the liver, cocaine signifi cantly decreased and nifedipine signifi cantly increased cytochrome P450, ethylmorphine-N-demethylase, and anilinehydroxylase in respect to control. In combination, nifedipine successfully countered cocaine effects on these enzymes. Urine cocaine excretion in the cocaine+nifedipine group signifi cantly dropped (by 35 %) compared to the cocaine-only group. Our results have confi rmed the effects of nifedipine against cocaine tolerance and development of dependence, most likely due to metabolic interactions between them. Vitcheva V, et al. INFLUENCE OF NIFEDIPINE ON COCAINE TOXICITY Arh Hig Rada Toksikol 2011;62:131-137 Multiple cocaine administration leads to behavioural activation, tolerance, and development of dependence in animals and humans (2). These adaptive changes in the central nervous system (CNS) are largely mediated by L-type calcium channels (3). One of the mechanisms underlying drug tolerance and dependence, and the related withdrawal syndrome, is a change in calcium homeostasis and the consequent activation of N-methyl-D-aspartate/nitric oxide (NMDA/NO) cascade (4). Changes in Ca 2+ homeostasis seem to be induced by calcium channel blockers of the 1,4-dihydropyridine type.
KEY WORDS: anilinehydroxylase, cytochrome P450, ethylmorphine-N-demethylase, GSH, nNOSIn our earlier studies (5-6), we have demonstrated that nifedipine, co-administered with morphine, attenuates withdrawal symptoms, which correlate with changes in the activity of neuronal nitric oxide synthase (nNOS) (5). Interactions between morphine and nifedipine in the liver and on the level of urine excretion were also observed, probably due to a metabolic interaction between these compounds (6).